| Name | Title | Contact Details |
|---|
Trinity Health - New England is an integrated health care delivery system comprised of world-class providers and facilities dedicated to the full spectrum of preventive, acute, and post-acute care, all delivered with the triple aim of better health, better care, and lower costs for our patient populations. In New England, our hospitals, walk-in clinics, medical offices, specialized facilities, affiliated institutions, and foundations serve a population of nearly 3 million people. As a dynamic part of Trinity Health, based in Livonia, Michigan, and one of the nation`s largest multi-institutional Catholic health care delivery systems, Trinity Health - New England is uniquely positioned to advance health care through alliances with the University of Connecticut School of Medicine, the Frank H. Netter MD School of Medicine at Quinnipiac University, and through our own research institutions dedicated to the development of primary care, new treatments for cancer and MS, and much more.
MedAmerica is one of the leading healthcare practice management organizations in the United States. Since 1975, we have successfully managed hospital-based physician group practices across the Acute Care Continuum, with expertise in emergency medicine, hospital medicine, ambulatory & urgent care, and other acute care specialties. We provide the strategy, solutions, and systems to help our clients successfully navigate today’s complex healthcare landscape. MedAmerica offers a full range of cost-effective practice management solutions. We’re in the business of enabling physician groups, hospitals, and other healthcare organizations to be more efficient, productive, and profitable – all while providing higher quality care and improved outcomes.
Beacon Specialized Living is a company that provides assisted living facilities and behavioral healthcare services for developmentally disabled, mentally ill, and autistic adults.
ACI Medical is a San Marcos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.